Filing Details
- Accession Number:
- 0001209191-17-048783
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-14 17:01:55
- Reporting Period:
- 2017-08-14
- Filing Date:
- 2017-08-14
- Accepted Time:
- 2017-08-14 17:01:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1539029 | Clearside Biomedical Inc. | CLSD | Pharmaceutical Preparations (2834) | 452437375 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1664690 | A. Charles Deignan | C/O Clearside Biomedical, Inc. 900 North Point Parkway, Suite 200 Alpharetta GA 30005 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-14 | 1,000 | $7.07 | 65,309 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $7.05 to $7.08, inclusive. The price reported in Column 4 is a weightedaverage price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer fullinformation regarding the number of shares and prices at which the transactions were effected.
Billionaire Hedge Funds
